INTEGRA LIFESCIENCES HOLDINGS CORP Earnings Per Share Disclosure
| Years Ended December 31, | |||||||||||||||||
| Dollars in thousands, except per share amounts | 2025 | 2024 | 2023 | ||||||||||||||
| Basic net (loss) income per share: | |||||||||||||||||
| Net (loss) income | $ | (516,474) | $ | (6,944) | $ | 67,741 | |||||||||||
| Weighted average common shares outstanding | 76,672 | 77,010 | 80,089 | ||||||||||||||
| Basic net (loss) income per common share | $ | (6.74) | $ | (0.09) | $ | 0.85 | |||||||||||
| Diluted net (loss) income per share: | |||||||||||||||||
| Net (loss) income | $ | (516,474) | $ | (6,944) | $ | 67,741 | |||||||||||
| Weighted average common shares outstanding — Basic | 76,672 | 77,010 | 80,089 | ||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||
| Stock options and restricted stock | — | — | 248 | ||||||||||||||
| Weighted average common shares for diluted earnings per share | 76,672 | 77,010 | 80,337 | ||||||||||||||
| Diluted net (loss) income per common share | $ | (6.74) | $ | (0.09) | $ | 0.84 | |||||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.